Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Physiological Response to Salbutamol and Exercise
NCT03902106Unknown
- Sponsor
- University of Copenhagen
- Start
- Mar 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of salbutamol in asthma (2 arms), sponsored by University of Copenhagen. Primary endpoints: Body composition at 6 weeks and Maximal oxygen consumption at 6 weeks. Status: unknown.
02
Drugs
salbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03902106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03902106.